Parabilis Medicines Stock (NASDAQ:PBLS)
Previous Close
$32.57
52W Range
$20.00 - $42.49
50D Avg
$36.32
200D Avg
$33.61
Market Cap
$3.72B
Avg Vol (3M)
$642.16K
Beta
-
Div Yield
-
PBLS Company Profile
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.